These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 29506964)

  • 1. Minimizing the risk of contrast-induced nephropathy and hemodynamic collapse during chronic total occlusion percutaneous coronary intervention with a percutaneous left ventricular assist device.
    Regazzoli D; Hachinohe D; Demir OM; Carlino M; Lemoine J; Mitomo S; Poletti E; Amor M; Colombo A; Azzalini L
    Cardiovasc Revasc Med; 2018 Sep; 19(6):712-716. PubMed ID: 29506964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impella-assisted chronic total occlusion percutaneous coronary interventions: A multicenter retrospective analysis.
    Riley RF; McCabe JM; Kalra S; Lazkani M; Pershad A; Doshi D; Kirtane AJ; Nicholson W; Kearney K; Demartini T; Aaron Grantham J; Moses J; Lombardi W; Karmpaliotis D
    Catheter Cardiovasc Interv; 2018 Dec; 92(7):1261-1267. PubMed ID: 30019817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous left ventricular assist device with TandemHeart for high-risk percutaneous coronary intervention: the Mayo Clinic experience.
    Alli OO; Singh IM; Holmes DR; Pulido JN; Park SJ; Rihal CS
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):728-34. PubMed ID: 22378485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recanalization of Chronic Total Occlusions in Patients With vs Without Chronic Kidney Disease: The Impact of Contrast-Induced Acute Kidney Injury.
    Azzalini L; Ojeda S; Demir OM; Dens J; Tanabe M; La Manna A; Benincasa S; Bellini B; Poletti E; Maccagni D; Hidalgo F; Chavarría J; Maeremans J; Gravina G; Miccichè E; D'Agosta G; Venuti G; Tamburino C; Pan M; Carlino M; Colombo A
    Can J Cardiol; 2018 Oct; 34(10):1275-1282. PubMed ID: 30269828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging-guided percutaneous coronary intervention with ultra-low contrast angiographic control for patients at extreme risk of contrast induced nephropathy.
    Pyka Ł; Hawranek M; Wilczek K; Piegza J; Szkodzinski J; Lekston A; Gąsior M
    Cardiol J; 2019; 26(6):796-798. PubMed ID: 31970738
    [No Abstract]   [Full Text] [Related]  

  • 6. Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella Registry.
    Maini B; Naidu SS; Mulukutla S; Kleiman N; Schreiber T; Wohns D; Dixon S; Rihal C; Dave R; O'Neill W
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):717-25. PubMed ID: 22105829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic Support With a Microaxial Percutaneous Left Ventricular Assist Device (Impella) Protects Against Acute Kidney Injury in Patients Undergoing High-Risk Percutaneous Coronary Intervention.
    Flaherty MP; Pant S; Patel SV; Kilgore T; Dassanayaka S; Loughran JH; Rawasia W; Dawn B; Cheng A; Bartoli CR
    Circ Res; 2017 Feb; 120(4):692-700. PubMed ID: 28073804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultra-Low Contrast Percutaneous Coronary Intervention to Minimize the Risk for Contrast-Induced Acute Kidney Injury in Patients With Severe Chronic Kidney Disease.
    Azzalini L; Laricchia A; Regazzoli D; Mitomo S; Hachinohe D; Bellini B; Demir OM; Poletti E; Maccagni D; Colombo A
    J Invasive Cardiol; 2019 Jun; 31(6):176-182. PubMed ID: 30865912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-induced nephropathy following chronic total occlusion percutaneous coronary intervention in patients with chronic kidney disease.
    Liu YH; Liu Y; Tan N; Chen JY; Zhou YL; Luo JF; Yu DQ; Li LW; Li HL; Ye P; Ran P
    Eur Radiol; 2015 Aug; 25(8):2274-81. PubMed ID: 25981215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anemia and periprocedural complications determine contrast-associated acute kidney injury after recanalization of chronic coronary occlusions in chronic kidney disease.
    Werner GS; Lorenz S; Dimitriadis Z; Krueger B
    Catheter Cardiovasc Interv; 2023 Jul; 102(1):101-110. PubMed ID: 37191280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Randomized Trial to Assess Regional Left Ventricular Function After Stent Implantation in Chronic Total Occlusion: The REVASC Trial.
    Mashayekhi K; Nührenberg TG; Toma A; Gick M; Ferenc M; Hochholzer W; Comberg T; Rothe J; Valina CM; Löffelhardt N; Ayoub M; Zhao M; Bremicker J; Jander N; Minners J; Ruile P; Behnes M; Akin I; Schäufele T; Neumann FJ; Büttner HJ
    JACC Cardiovasc Interv; 2018 Oct; 11(19):1982-1991. PubMed ID: 30219327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrograde recanalization of a nonchronic total occlusion lesion.
    Siraj A; Pattanshetty DJ; Agarwal SK; Uretsky BF
    Catheter Cardiovasc Interv; 2018 Dec; 92(7):1293-1296. PubMed ID: 30265428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-in-human experience with Aortix intraaortic pump.
    Vora AN; Schuyler Jones W; DeVore AD; Ebner A; Clifton W; Patel MR
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):428-433. PubMed ID: 30311400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous retrograde left ventricular assist support for interventions in patients with aortic stenosis and left ventricular dysfunction.
    Martinez CA; Singh V; Londoño JC; Cohen MG; Alfonso CE; O'Neill WW; Heldman AW
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1201-9. PubMed ID: 22511541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced Hybrid Complete Revascularization with TECAB and Impella-Assisted PCI of CTO.
    Hirai T; Kitahara H; Balkhy HH; Blair JEA
    Cardiovasc Revasc Med; 2019 Nov; 20(11S):51-54. PubMed ID: 30930011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of CTO treated with minimum use of contrast media.
    Uehara Y; Shimizu M; Yoshimura M
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):E884-7. PubMed ID: 23359535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous Coronary Intervention Under Cover of Left Ventricular Assist Device (Impella 2.5).
    Iftikhar I; Khan HS; Kayani AM; Shahzad H
    J Coll Physicians Surg Pak; 2015 Oct; 25 Suppl 2():S78-80. PubMed ID: 26522210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful Complete Revascularization With PCI Using Super-Low Volume of Contrast Medium in a Patient With Three-Vessel Disease Including 2 Chronic Total Occlusions With Severe Renal Dysfunction.
    Koide M; Kato M; Usui K; Mera K; Tsubakimoto Y; Isodono K; Sakatani T; Matsuo A; Inoue K; Fujita H
    Int Heart J; 2017 Aug; 58(4):624-628. PubMed ID: 28690297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zero-contrast percutaneous coronary intervention on calcified lesions facilitated by rotational atherectomy.
    Karimi Galougahi K; Mintz GS; Karmpaliotis D; Ali ZA
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):E85-E89. PubMed ID: 28303645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated homocysteine and the risk of contrast-induced nephropathy: a cohort study.
    Barbieri L; Verdoia M; Schaffer A; Niccoli G; Perrone-Filardi P; Bellomo G; Marino P; Suryapranata H; Luca GD
    Angiology; 2015 Apr; 66(4):333-8. PubMed ID: 24830422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.